ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
FTSE 100
8,320.98
0.11%
Dow Jones
43,914.12
-0.53%
Gold vs US Dollar
2,670.175
-0.39%
Brent Oil
73.735
0.72%
Bitcoin
100,180.94
0.12%
Pepperstone
Advertisement
Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. UK
  5. LSE
  6. Crism Therapeutics Corporation (CRTX)

  7. Crism Therapeutics Corporation (CRTX) News

Crism Therapeutics (CRTX)

Crism Therapeutics Corporation
Date:
Sort by:
 Showing the most relevant articles for your search:LSE:CRTX
DateTimeSourceHeadlineSymbolCompany
19/09/202406:00RNS Regulatory NewsCRISM Therapeutics Corporation Interim ResultsLSE:CRTXCrism Therapeutics Corporation
09/09/202406:00RNS Regulatory NewsCRISM Therapeutics Corporation Notice of Interim Results & IMC PresentationLSE:CRTXCrism Therapeutics Corporation
03/09/202406:00RNS Non-RegulatoryCRISM Therapeutics Corporation Delivery Method Validated in Peer Reviewed JournalLSE:CRTXCrism Therapeutics Corporation
02/09/202406:00RNS Regulatory NewsCRISM Therapeutics Corporation Innovation Passport AwardLSE:CRTXCrism Therapeutics Corporation
30/07/202406:00RNS Regulatory NewsCrism Therapeutics Corporation CRISM Signs Service Agreement ContractLSE:CRTXCrism Therapeutics Corporation
03/07/202418:03Alliance NewsAlliance NewsIN BRIEF: Crism flags contract talks, reacts to share price surgeLSE:CRTXCrism Therapeutics Corporation
03/07/202415:18RNS Regulatory NewsCrism Therapeutics Corporation Response to Movement in Share PriceLSE:CRTXCrism Therapeutics Corporation
03/06/202414:25RNS Regulatory NewsCrism Therapeutics Corporation Director DealingLSE:CRTXCrism Therapeutics Corporation
31/05/202420:58Alliance NewsAlliance NewsIN BRIEF: Crism has first day of trade on AIM after name change, buyLSE:CRTXCrism Therapeutics Corporation
31/05/202406:00RNS Regulatory NewsCrism Therapeutics Corporation Admission to Trading and First Day of DealingsLSE:CRTXCrism Therapeutics Corporation
18/12/200918:45PR Newswire (US)Cornerstone Therapeutics to Host Conference Call to Discuss Financial Guidance for 2010LSE:CRTX
20/11/200920:40PR Newswire (US)Cornerstone Therapeutics Provides a Response to FDA Warning Letter on DeconsalLSE:CRTX
16/11/200913:00PR Newswire (US)Cornerstone Therapeutics to Present at the 6th Annual Lazard Capital Markets Healthcare ConferenceLSE:CRTX
13/11/200913:00PR Newswire (US)Cornerstone Therapeutics Appoints General CounselLSE:CRTX
04/11/200912:00PR Newswire (US)Cornerstone Therapeutics Reports Third Quarter 2009 Financial ResultsLSE:CRTX
21/10/200912:00PR Newswire (US)Cornerstone Therapeutics to Host Third Quarter 2009 Conference CallLSE:CRTX
03/09/200912:01PR Newswire (US)Cornerstone Therapeutics Receives Approval to Acquire Commercial Rights to the Antibiotic Factive(R)LSE:CRTX
03/09/200912:00PR Newswire (US)Cornerstone Therapeutics to Present at Two Upcoming Investor ConferencesLSE:CRTX
20/07/200912:00PR Newswire (US)Cornerstone Therapeutics' David Price Named 2009 Chief Financial Officer of the Year by the Triangle Business JournalLSE:CRTX
15/07/200923:04PR Newswire (US)Cornerstone Therapeutics Submits Regulatory Filing for Extended-Release Antitussive ProductLSE:CRTX
08/07/200920:15PR Newswire (US)Cornerstone Therapeutics Inc. Announces Record Date and Meeting Date for Special Meeting of Stockholders for Vote with Respect tLSE:CRTX
12/06/200920:35Dow Jones NewsUPDATE:FDA Updates Singulair Label For Neuropsychiatric EventsLSE:CRTXCornerstone Therapeutics Inc.
12/06/200919:28Dow Jones NewsFDA: Updates Singulair Label For Neuropsychiatric EventsLSE:CRTXCornerstone Therapeutics Inc.
19/05/200920:01PR Newswire (US)Cornerstone Therapeutics Announces Management ChangeLSE:CRTX
07/05/200911:01PR Newswire (US)Cornerstone Therapeutics Announces $70 Million Strategic Transaction With Chiesi Farmaceutici SpALSE:CRTX
07/05/200911:00PR Newswire (US)Cornerstone Therapeutics Reports First Quarter 2009 Financial ResultsLSE:CRTX
27/04/200912:00PR Newswire (US)Cornerstone Therapeutics to Host First Quarter 2009 Conference CallLSE:CRTX
13/01/200922:33Dow Jones NewsUPDATE: Singular, Zyflo Asthma Drug Safety Review ContinuesLSE:CRTXCornerstone Therapeutics Inc.
13/01/200920:34Dow Jones NewsFDA: Singular, Zyflo Asthma Drug Safety Review ContinuesLSE:CRTXCornerstone Therapeutics Inc.
05/11/200813:00PR Newswire (US)Cornerstone Therapeutics Announces New Board of DirectorsLSE:CRTX
 Showing the most relevant articles for your search:LSE:CRTX

Your Recent History

LSE
THG
Thg
LSE
SBTX
Skinbiotherapeutics
LSE
TXP
Touchstone Exploration
LSE
BOO
Boohoo
LSE
AAU
Ariana Resources
LSE
TW.
Taylor Wimpey
LSE
EME
Empyrean Energy
LSE
VRS
Versarien
LSE
POS
Plexus
LSE
NFDS
Northern Foods
LSE
AAZ
Anglo Asian Mining
LSE
OMI
Orosur Mining
LSE
APTA
Aptamer
LSE
GGP
Greatland Gold
LSE
GLEN
Glencore
LSE
YU.
Yu
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved